Literature DB >> 22025031

Hepatocellular carcinoma: insight from animal models.

Yan Li1, Zhao-You Tang, Jin-Xuan Hou.   

Abstract

Hepatocellular carcinoma (HCC) ranks as the third most common cause of death from cancer worldwide. Although major risk factors for the development of HCC have been defined, many aspects of the evolution of hepatocellular carcinogenesis and metastasis are still unknown. Suitable animal models are, therefore, essential to promote our understanding of the molecular, cellular and pathophysiological mechanisms of HCC and for the development of new therapeutic strategies. This Review provides an overview of animal models that are relevant to HCC development, metastasis and treatment. For HCC development, this Review focuses on transgenic mouse models of HBV and HCV infection, which provide experimental evidence that viral genes could initiate or promote liver carcinogenesis. Animal models of HCC metastasis provide platforms to elucidate the mechanisms of HCC metastasis, to study the interaction between the microenvironment and HCC invasion and to conduct intervention studies. In addition, animal models have been developed to investigate the effects of new treatment modalities. The criteria for establishing ideal HCC animal models are also discussed.

Entities:  

Mesh:

Year:  2011        PMID: 22025031     DOI: 10.1038/nrgastro.2011.196

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  117 in total

Review 1.  RNA interference-mediated prevention and therapy for hepatocellular carcinoma.

Authors:  P R Romano; D E McCallus; C J Pachuk
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

2.  CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Authors:  Xin-Rong Yang; Yang Xu; Bin Yu; Jian Zhou; Jia-Chu Li; Shuang-Jian Qiu; Ying-Hong Shi; Xiao-Ying Wang; Zhi Dai; Guo-Ming Shi; Bin Wu; Li-Ming Wu; Guo-Huan Yang; Bo-Heng Zhang; Wen-Xin Qin; Jia Fan
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

3.  Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.

Authors:  Volker Schmitz; Esther Raskopf; Maria Angeles Gonzalez-Carmona; Annabelle Vogt; Christian Rabe; Ludger Leifeld; Miroslaw Kornek; Tilman Sauerbruch; Wolfgang H Caselmann
Journal:  Gut       Date:  2006-06-29       Impact factor: 23.059

Review 4.  Pathogenesis of hepatitis C-associated hepatocellular carcinoma.

Authors:  T Jake Liang; Theo Heller
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus.

Authors:  Hervé Lerat; Masao Honda; Michael R Beard; Kim Loesch; Jiaren Sun; Yan Yang; Michiari Okuda; Rainer Gosert; Shu-Yuan Xiao; Steven A Weinman; Stanley M Lemon
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

6.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.

Authors:  Y Li; Y Tang; L Ye; B Liu; K Liu; J Chen; Q Xue
Journal:  J Cancer Res Clin Oncol       Date:  2002-12-04       Impact factor: 4.553

7.  AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma.

Authors:  Hung Huynh; Pierce K H Chow; Khee-Chee Soo
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

8.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

Review 9.  Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.

Authors:  L R Kelland
Journal:  Eur J Cancer       Date:  2004-04       Impact factor: 9.162

10.  Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.

Authors:  Lihua Ming; Snorri S Thorgeirsson; Mitchell H Gail; Peixin Lu; Curtis C Harris; Nengjin Wang; Yongfu Shao; Zhiyuan Wu; Guoting Liu; Xiaohong Wang; Zongtang Sun
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

View more
  45 in total

1.  Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.

Authors:  Junki Hirano; Toru Okamoto; Yukari Sugiyama; Tatsuya Suzuki; Shinji Kusakabe; Makoto Tokunaga; Takasuke Fukuhara; Miwa Sasai; Takahiro Tougan; Yasue Matsunaga; Kazuo Yamashita; Yusuke Sakai; Masahiro Yamamoto; Toshihiro Horii; Daron M Standley; Kohji Moriishi; Kyoji Moriya; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-29       Impact factor: 11.205

Review 2.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

3.  Generation of subcutaneous and intrahepatic human hepatocellular carcinoma xenografts in immunodeficient mice.

Authors:  Sharif U Ahmed; Murtuza Zair; Kui Chen; Matthew Iu; Feng He; Oyedele Adeyi; Sean P Cleary; Anand Ghanekar
Journal:  J Vis Exp       Date:  2013-09-25       Impact factor: 1.355

Review 4.  Hepatic stellate cells in liver development, regeneration, and cancer.

Authors:  Chunyue Yin; Kimberley J Evason; Kinji Asahina; Didier Y R Stainier
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 5.  Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes.

Authors:  Yuan-Chi Teng; Zhao-Qing Shen; Cheng-Heng Kao; Ting-Fen Tsai
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Authors:  C Trierweiler; B Hockenjos; K Zatloukal; R Thimme; H E Blum; E F Wagner; P Hasselblatt
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

7.  Transcriptomic analysis of the woodchuck model of chronic hepatitis B.

Authors:  Simon P Fletcher; Daniel J Chin; Yongmei Ji; A Leonardo Iniguez; Bruce Taillon; David C Swinney; Palanikumar Ravindran; Donavan T Cheng; Hans Bitter; Uri Lopatin; Han Ma; Klaus Klumpp; Stephan Menne
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

8.  Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma.

Authors:  Ying-Ying Lee; Myth T S Mok; Alfred Sze-Lok Cheng
Journal:  Hepatobiliary Surg Nutr       Date:  2014-04       Impact factor: 7.293

Review 9.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

Review 10.  Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

Authors:  Virginia Hernandez-Gea; Sara Toffanin; Scott L Friedman; Josep M Llovet
Journal:  Gastroenterology       Date:  2013-01-09       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.